Diphemanil metilsulfate: Difference between revisions
CSV import Tags: mobile edit mobile web edit |
CSV import |
||
| Line 1: | Line 1: | ||
== Diphemanil Metilsulfate == | |||
[[File:Diphemanil_metilsulfate.png|thumb|right|Chemical structure of Diphemanil Metilsulfate]] | |||
'''Diphemanil Metilsulfate''' is a [[quaternary ammonium compound]] used primarily as an [[anticholinergic]] agent. It is commonly employed in the treatment of [[gastrointestinal disorders]] and [[hyperhidrosis]]. | |||
== Pharmacology == | == Pharmacology == | ||
Diphemanil | Diphemanil Metilsulfate functions by inhibiting the action of [[acetylcholine]] on [[muscarinic receptors]]. This action reduces the secretions of various exocrine glands and decreases the motility of the [[gastrointestinal tract]]. | ||
=== Mechanism of Action === | |||
The compound acts as a competitive antagonist at muscarinic receptors, which are part of the [[parasympathetic nervous system]]. By blocking these receptors, Diphemanil Metilsulfate reduces the effects of parasympathetic stimulation, leading to decreased glandular secretions and reduced smooth muscle contractions. | |||
== Clinical Uses == | |||
Diphemanil Metilsulfate is used in the management of several conditions: | |||
* '''[[Hyperhidrosis]]''': It helps in reducing excessive sweating by inhibiting sweat gland activity. | |||
* '''[[Peptic ulcer disease]]''': The drug decreases gastric acid secretion, providing relief from ulcer symptoms. | |||
* '''[[Irritable bowel syndrome]] (IBS)''': It alleviates symptoms by reducing intestinal motility and secretions. | |||
== Side Effects == | == Side Effects == | ||
Common side effects of Diphemanil Metilsulfate include: | |||
* [[Dry mouth]] | |||
* [[Constipation]] | |||
* [[Blurred vision]] | |||
* [[Urinary retention]] | |||
These side effects are typical of anticholinergic agents due to their action on muscarinic receptors. | |||
== Contraindications == | == Contraindications == | ||
Diphemanil | Diphemanil Metilsulfate should not be used in patients with: | ||
* [[Glaucoma]] | |||
* [[Myasthenia gravis]] | |||
* [[Prostatic hypertrophy]] | |||
== | == Related Pages == | ||
* [[Anticholinergic]] | * [[Anticholinergic]] | ||
* [[ | * [[Muscarinic receptor]] | ||
* [[Quaternary ammonium compound]] | |||
{{Pharmacology}} | |||
[[Category:Anticholinergics]] | |||
[[Category:Quaternary ammonium compounds]] | |||
Latest revision as of 16:32, 16 February 2025
Diphemanil Metilsulfate[edit]

Diphemanil Metilsulfate is a quaternary ammonium compound used primarily as an anticholinergic agent. It is commonly employed in the treatment of gastrointestinal disorders and hyperhidrosis.
Pharmacology[edit]
Diphemanil Metilsulfate functions by inhibiting the action of acetylcholine on muscarinic receptors. This action reduces the secretions of various exocrine glands and decreases the motility of the gastrointestinal tract.
Mechanism of Action[edit]
The compound acts as a competitive antagonist at muscarinic receptors, which are part of the parasympathetic nervous system. By blocking these receptors, Diphemanil Metilsulfate reduces the effects of parasympathetic stimulation, leading to decreased glandular secretions and reduced smooth muscle contractions.
Clinical Uses[edit]
Diphemanil Metilsulfate is used in the management of several conditions:
- Hyperhidrosis: It helps in reducing excessive sweating by inhibiting sweat gland activity.
- Peptic ulcer disease: The drug decreases gastric acid secretion, providing relief from ulcer symptoms.
- Irritable bowel syndrome (IBS): It alleviates symptoms by reducing intestinal motility and secretions.
Side Effects[edit]
Common side effects of Diphemanil Metilsulfate include:
These side effects are typical of anticholinergic agents due to their action on muscarinic receptors.
Contraindications[edit]
Diphemanil Metilsulfate should not be used in patients with:
Related Pages[edit]
| Pharmacology | ||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|